The BCG-OPPI report, launched at the OPPI Annual Summit 2024, highlights India's pharmaceutical market, currently valued at $60 billion, is set to double by 2030, driven by a robust ecosystem and government initiatives. Global pharmaceutical companies are expected to achieve over 10% annual growth, emphasizing the need for tailored strategies to navigate local market dynamics. The report outlines eight principles to help these companies capitalize on India's vast potential and align with the vision of a "Viksit Bharat" by 2047.